J. Otto

18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns

J. Darcourt, R. Schiappa, P. Koulibaly, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer.

P. Bondiau, A. Naghavi, J. Lacour, 2022, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.

C. Marquette, J. Sabourin, P. Hofman, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor Genomic Profiling Reports from Different Vendors: A Comparison with Respect to Clinical Action Ability of the Provided Data

V. Levenson, Y. Mori, J. Otto, 2016 .

Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors.

A. Italiano, P. Marcy, D. Fontaine, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

C. Marquette, P. Hofman, V. Hofman, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.